Envestnet Asset Management Inc. Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Envestnet Asset Management Inc. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 338,914 shares of the company’s stock after acquiring an additional 46,231 shares during the period. Envestnet Asset Management Inc. owned approximately 0.07% of GE HealthCare Technologies worth $25,452,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. Norges Bank bought a new stake in GE HealthCare Technologies in the 2nd quarter worth approximately $468,120,000. Holocene Advisors LP boosted its stake in GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after buying an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. bought a new position in GE HealthCare Technologies during the second quarter valued at approximately $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new position in shares of GE HealthCare Technologies during the second quarter worth approximately $58,388,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.7%

NASDAQ GEHC opened at $78.65 on Friday. The stock has a market cap of $35.84 billion, a P/E ratio of 17.25, a price-to-earnings-growth ratio of 1.75 and a beta of 1.08. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The stock has a 50 day simple moving average of $82.54 and a two-hundred day simple moving average of $77.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Bank of America upped their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Piper Sandler boosted their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.